ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study (CABG-PRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01063491
Recruitment Status : Unknown
Verified October 2013 by Emmanouil Brilakis, North Texas Veterans Healthcare System.
Recruitment status was:  Active, not recruiting
First Posted : February 5, 2010
Last Update Posted : November 1, 2013
Sponsor:
Information provided by (Responsible Party):
Emmanouil Brilakis, North Texas Veterans Healthcare System

February 4, 2010
February 5, 2010
November 1, 2013
February 2010
December 2013   (Final data collection date for primary outcome measure)
Per patient bypass graft failure (defined as ≥75% graft diameter stenosis) in at least one bypass graft, as assessed by quantitative coronary angiography performed at 12 months. [ Time Frame: 12 months ]
Same as current
Complete list of historical versions of study NCT01063491 on ClinicalTrials.gov Archive Site
  • Per graft incidence of bypass graft failure; per graft incidence of bypass graft occlusion; and per patient incidence of at least one bypass graft occlusion [ Time Frame: 12 months ]
  • Major adverse cardiac events (death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, and composite of death/myocardial infarction) [ Time Frame: 12 months ]
  • Mean SVG lumen diameter and wall thickness, as assessed by intravascular ultrasonography and mean lipid core burden index, as assessed by near-infrared intracoronary spectroscopy [ Time Frame: 12 months ]
Same as current
Not Provided
Not Provided
 
Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study
Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study

Aortocoronary bypass graft failure is common and is associated with high morbidity and mortality. Failure of saphenous vein grafts is more common than failure of internal mammary artery grafts. Whether early graft angiography can reduce bypass graft failure remains unknown. The Cardiac CAtheterization for Bypass Graft Patency Rate Optimization (CABG-PRO) randomized-controlled pilot study is a phase III, double-blind, randomized-controlled pilot trial that will randomize 170 patients undergoing coronary artery bypass graft surgery to early (before dismissal) graft angiography vs. no early graft angiography. Coronary angiography will be performed at 12 months, to determine whether compared to no early graft angiography, early graft angiography will result in:

  1. lower per patient angiographic bypass graft failure (in at least one graft) rates (defined as ≥75% diameter stenosis in at least one bypass graft) (primary efficacy endpoint)
  2. lower per graft failure rates, per graft occlusion rates, and per patient bypass graft occlusion rates (in at least one bypass graft) (secondary endpoints)
  3. lower incidence major adverse cardiac events (death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, and composite of death/myocardial infarction) (secondary endpoint)

Intravascular ultrasonography and near-infrared spectroscopy will also be performed in at least one bypass graft at baseline (in the early graft angiography group only) and at 12-month angiographic follow-up to evaluate the structural bypass graft changes occurring after coronary artery bypass graft surgery (secondary endpoint).

Not Provided
Interventional
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Coronary Artery Bypass Graft Surgery
Procedure: bypass graft angiography
  • Experimental: Early graft angiography after coronary artery bypass surgery
    Treatment of any bypass graft abnormalities that are discovered will be performed if needed
    Intervention: Procedure: bypass graft angiography
  • No Intervention: No early angiography after coronary artery bypass surgery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
170
Same as current
December 2013
December 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Age >18 years
  2. Willing and able to give informed consent. The patients must be able to comply with study procedures and follow-up.
  3. Undergoing clinically-indicated coronary artery bypass graft surgery

Exclusion Criteria:

  1. Positive pregnancy test or breast-feeding
  2. Coexisting conditions that limit life expectancy to less than 12 months or that could affect a patient's compliance with the protocol
  3. Serum creatinine > 2.5 mg/dL or acute renal failure
  4. Severe peripheral arterial disease limiting vascular access
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01063491
10-001
Yes
Not Provided
Not Provided
Emmanouil Brilakis, North Texas Veterans Healthcare System
North Texas Veterans Healthcare System
Not Provided
Not Provided
North Texas Veterans Healthcare System
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP